Loading…
Jfl Life Sciences (JFLLIFE)₹12.90+4.45%Pharmaceuticals
At the end of the Jun 2026 quarter, Jfl Life Sciences' shareholders were: promoters 67.49%, public 32.51%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 942 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 67.49% | 67.49% | 67.49% | 67.49% | 67.49% | 67.49% | 67.49% | 67.49% | 67.49% |
| Public | 32.51% | 32.51% | 32.51% | 32.51% | 32.51% | 32.51% | 32.51% | 32.51% | 32.51% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 831 | 824 | 965 | 996 | 1,007 | 997 | 990 | 970 | 942 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Smiral Ashwinkumar Patel | Promoter | 44.38% | 0.00 |
| Tejal Smiral Patel | Promoter | 16.59% | 0.00 |
| Smiral Ashwinkumar Patel Huf | Promoter | 4.01% | 0.00 |
| Pratik Rajendrabhai Gandhi | Public | 1.21% | 0.00 |
| Ashwinbhai Jivrambhai Patel | Promoter | 0.90% | 0.00 |
| Patel Dakshaben | Promoter | 0.37% | 0.00 |
| Rupesh Kirtibhai Patel | Promoter | 0.34% | 0.00 |
| Ashokkumar Parshottamdas Patel | Promoter | 0.27% | 0.00 |
| Ushaben Ashokkumar Patel | Promoter | 0.21% | 0.00 |
| Artiben Manishkumar Patel | Promoter | 0.20% | 0.00 |
| Shobhnaben Kirtikumar Patel | Promoter | 0.18% | 0.00 |
| Kirtikumar Parshottambhai Patel | Promoter | 0.12% | 0.00 |
Promoters held 67.49% of Jfl Life Sciences at the end of the Jun 2026 quarter, the same as a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Jfl Life Sciences had 942 shareholders at the end of the Jun 2026 quarter, against 1,007 a year earlier.
Pratik Rajendrabhai Gandhi (Public) held 1.21% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.